Analyst Ratings for Incyte (incy)
incy Rating Summary
incy Price Target Summary
- Highest: $140.00 (H.C. Wainwright)
- Lowest: $90.00 (Goldman Sachs)
- Average: $110.57
* Over Last 12-Mos
Overall Rating:
NEUTRAL
Rating Trend:
Avg. $ Target:
$110.57 (-3.3%)
* Over Last 12-Mos
Rating Score: 4.9 / 10
Percentile Rank: 48%
Avg. $ Target:
$110.57 (-3.3%)
* Over Last 12-Mos
Rating Score: 4.9 / 10
Percentile Rank: 48%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 6/22/2026 | BMO Capital | Evan David Seigerman | Upgrade | Market Perform (Underperform) |
94.00 (75.00) |
98.99 (114.32) |
15.49% | Details |
| 5/21/2026 | Bernstein SocGen Group | Jeffrey Walch | New Coverage | Market Perform (N/A) |
99.00 (N/A) |
97.08 (114.32) |
17.76% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
